Cochrane has recently created eight new Networks of Cochrane Review Groups (CRGs). The formation of these networks provides a timely opportunity to review the scope of all CRGs and to consider changes where appropriate. In response to concerns raised by members of the Chronic fatigue syndrome (CFS)/myalgic encephalomyelitis (or encephalopathy) (ME) community, Cochrane has been considering repositioning the editorial oversight of CFS/ME reviews.
The Cochrane Common Mental Disorders Review Group currently sits within the Brain, Nerves and Mind (BNM) Network. In the future, reviews on this topic might sit with another Cochrane Review Group within the BNM Network, or they might transfer to another Network altogether, such as the Long Term Conditions and Ageing 2 Network.
This is currently under consideration and a decision is anticipated before the end of 2018.